mRNA Vaccines Conquering COVID-19 Today—Will It Be Cancer Tomorrow?

Prior to the advent of COVID-19, more than a decade’s worth of research & discovery set the stage for timely development of these COVID-19 vaccines—a large part of this research had been focused on mRNA cancer vaccines. With the success of the COVID-19 vaccines, we now know that this approach is a viable option for cancer vaccines and data suggests it is an effective approach.  

Learn More:
https://www.curetoday.com/view/fda-approves-keytruda-as-initial-treatment-for-advanced-colorectal-cancer-with-dna-repair-defects

Previous
Previous

Expert Panel Advises Everyone With Cancer To Get The COVID-19 Vaccine

Next
Next

Th Jacqueline Rush Foundation Featured on Lifetime’s Access Health!